Rituximab for patients with nephrotic syndrome

Lancet. 2015 Jan 17;385(9964):225-6. doi: 10.1016/S0140-6736(15)60050-2.

Authors

Jae Il Shin¹, Andreas Kronbichler²

Affiliations

¹ Department of Pediatrics, Yonsei University College of Medicine, Severance Children's Hospital, Seoul, Korea.
² Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Innsbruck 6020, Austria. Electronic address: [email protected].

PMID: 25706700
DOI: 10.1016/S0140-6736(15)60050-2

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Murine-Derived / therapeutic use*
Female
Glucocorticoids / therapeutic use*
Humans
Immunosuppressive Agents / therapeutic use*
Male
Nephrotic Syndrome / drug therapy*

Substances

Antibodies, Monoclonal, Murine-Derived
Glucocorticoids
Immunosuppressive Agents